NDC 73377-019 - Dorzolamide Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73377-019
- Package NDCs from labels
- 73377-019-01, 73377-019-02
- Manufacturer
- AX Pharmaceutical Corp
- Effective date
- 2020-09-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dorzolamide Hydrochloride - AX Pharmaceutical Corp | AX Pharmaceutical Corp | 2020-09-16 | BULK INGREDIENT |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73377-019-01 | Dorzolamide Hydrochloride | 50 g in 1 JAR | POWDER | 50 | 2 | |
| 73377-019-02 | Dorzolamide Hydrochloride | 100 g in 1 JAR | POWDER | 100 | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dorzolamide Hydrochloride and Timolol Maleate Preservative Free | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE PRESERVATIVE FREE | Aurobindo Pharma Limited | f41a9cd5-48c8-42eb-bb1b-d0355d981201 | 2026-08-13 | Warnings, Adverse reactions | QZO5366EW7 |
| Dorzolamide Hydrochloride and Timolol Maleate | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | Aurobindo Pharma Limited | 2d5dcaa5-97ee-40c3-aa29-fcfb91fb78e1 | 2026-08-13 | Warnings, Adverse reactions | QZO5366EW7 |
| Dorzolamide HCl | DORZOLAMIDE HCL | Bausch & Lomb Incorporated | 8417d162-65a1-4266-bca7-707af1193bf3 | 2026-06-29 | Warnings, Adverse reactions | QZO5366EW7 |
| Dorzolamide Hydrochloride Ophthalmic | DORZOLAMIDE HYDROCHLORIDE OPHTHALMIC | Florida Pharmaceutical Products, LLC | e4e6a5a8-f7be-4424-83f2-d6bb4d57443e | 2026-06-24 | Warnings, Adverse reactions | QZO5366EW7 |
| Dorzolamide Hydrochloride and Timolol Maleate ophthalmic Solution | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | Bryant Ranch Prepack | 09dbed18-9076-4891-93a7-d14bb2217926 | 2026-06-12 | Warnings, Adverse reactions | QZO5366EW7 |
| DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALEATE | DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALEATE | Florida Pharmaceutical Products, LLC | 02d89d37-cbca-4e06-83ef-2a10f988f1ea | 2026-06-12 | Warnings, Adverse reactions | QZO5366EW7 |
| COSOPT PF | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | Thea Pharma Inc. | 535fc801-8c3f-4974-a120-3eff1d5a5062 | 2026-05-13 | Warnings, Adverse reactions | QZO5366EW7 |
| Dorzolamide Hydrochloride and Timolol Maleate | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | Bryant Ranch Prepack | ff76c0cf-256c-4015-94f4-405f0c46205f | 2026-05-01 | Warnings, Adverse reactions | QZO5366EW7 |
| DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE PRESERVATIVE FREE | Micro Labs Limited | b0a1d984-efee-4751-9797-c09adc2d307d | 2026-04-30 | Warnings, Adverse reactions | QZO5366EW7 |
| Dorzolamide Hydrochloride | DORZOLAMIDE HYDROCHLORIDE | Sagent Pharmaceuticals | 0246463c-6c24-4611-8e22-2d5254ace66a | 2026-01-09 | Warnings, Adverse reactions | QZO5366EW7 |
| DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALETAE | DDORZOLAMIDE HYDROCHLORIDE TIMOLOL MALEATE | Indoco Remedies Limited | 0b75a79a-e048-4bf1-b02b-a72a8b8a0b3b | 2025-12-22 | Warnings, Adverse reactions | QZO5366EW7 |
| Dorzolamide Hydrochloride | DORZOLAMIDE HYDROCHLORIDE | FOSUN PHARMA USA INC | ef173b63-499f-301b-e053-2995a90a4771 | 2025-09-26 | Warnings, Adverse reactions | QZO5366EW7 |
| Dorzolamide Hydrochloride and Timolol Maleate | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | Akorn | 4e90c721-21e8-46ea-ab49-19f535bf7202 | 2025-09-10 | Warnings, Adverse reactions | QZO5366EW7 |
| Dorzolamide Hydrochloride | DORZOLAMIDE HYDROCHLORIDE | Gland Pharma Limited | 2023e603-12bb-4502-9f93-0126e0cc24ed | 2025-05-10 | Warnings, Adverse reactions | QZO5366EW7 |
| DORZOLAMIDE HYDROCHLORIDE | DORZOLAMIDE HYDROCHLORIDE | Advagen Pharma Ltd. | ed9d1658-43cc-4c78-b3d8-e7d980a6b673 | 2025-02-28 | Warnings, Adverse reactions | QZO5366EW7 |
| Dorzolamide Hydrochloride | DORZOLAMIDE HYDROCHLORIDE | Somerset Therapeutics, LLC | 0832960f-0a6f-4fd1-bf55-be9bebde53bd | 2025-02-12 | Warnings, Adverse reactions | QZO5366EW7 |
| Dorzolamide Hydrochloride Ophthalmic Solution | DORZOLAMIDE HYDROCHLORIDE | Micro Labs Limited | 4698e4e1-c5f6-4db1-9328-74464a85afea | 2025-01-08 | Warnings, Adverse reactions | QZO5366EW7 |
| Dorzolamide HCl | DORZOLAMIDE HCL | A-S Medication Solutions | 91df460c-b896-4600-9d33-e499b49ba1b6 | 2024-11-11 | Warnings, Adverse reactions | QZO5366EW7 |
| Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION | Alembic Pharmaceuticals Limited | 2b1fa44a-3890-4634-bcfc-c7310b51128e | 2024-11-06 | Warnings, Adverse reactions | QZO5366EW7 |
| Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION | Alembic Pharmaceuticals Inc. | 6b9c446e-7068-479b-8611-aead7a8d2f50 | 2024-11-06 | Warnings, Adverse reactions | QZO5366EW7 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.